Back to top

Image: Bigstock

What's Next For Nike, More NCAA News, & Another New Football League

Read MoreHide Full Article

Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research. On this week’s episode, we dive into Nike’s (NKE - Free Report) recent quarterly results and begin to take a look at the company’s growth initiatives. We then transition to the latest financial news surrounding NCAA March Madness, as well as a discussion about NBA micro-transactions, and the recently announced Alliance of American Football.

Nike saw its North American revenues dip once again in Q3 as it faces further competition from rival sportswear power Adidas (ADDYY - Free Report) . Shifting consumer habits have also led to lower sales at retail locations such as Dick’s Sporting Goods (DKS - Free Report) , Foot Locker (FL - Free Report) , and Finish Line .

However, in the long run, these challenges might have forced Nike to make changes to its business that could transform the company for the better.

Along with a detailed discussion about Nike, we dove into some of the money a long March Madness run can bring schools and coaches. The conversation then flows to some potentially game-changing news out of the NBA regarding its trial run of small, micro-payments for non-NBA League Pass customers.

This week’s episode ends with a look at another new football league that is set to debut in 2019, amid declining NFL ratings. The Alliance of American Football aims to capitalize on the NFL’s offseason and make some fan-friendly changes to the game.

Charlie Ebersol’s new football league, which looks like it will compete directly against Vince McMahon’s new XFL, will offer free live streaming on the league’s app as well as weekly games on CBS .

Make sure to listen to the whole podcast to hear everything you’ll need to know about the latest happenings in the sports business world. 

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


NIKE, Inc. (NKE) - free report >>

Foot Locker, Inc. (FL) - free report >>

DICK'S Sporting Goods, Inc. (DKS) - free report >>

Adidas AG (ADDYY) - free report >>